Descriptor English: | Ustekinumab | ||||
Descriptor Spanish: |
Ustekinumab
| ||||
Descriptor Portuguese: | Ustekinumab | ||||
Descriptor French: | Ustékinumab | ||||
Entry term(s): |
CNTO 1275 CNTO-1275 Stelara |
||||
Tree number(s): |
D12.776.124.486.485.114.224.060.937 D12.776.124.790.651.114.224.060.937 D12.776.377.715.548.114.224.200.937 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000069549 | ||||
Scope note: | A humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies. |
||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification DE drug effects EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||
Pharm Action: |
Dermatologic Agents |
||||
Registry Number: | FU77B4U5Z0 | ||||
Public MeSH Note: | 2016; USTEKINUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2011-2015; and under ANTIBODIES, MONOCLONAL 2005-2011 |
||||
History Note: | 2016 (2005) |
||||
Related: |
Interleukin-12
MeSH Interleukin-23 MeSH | ||||
DeCS ID: | 55981 | ||||
Unique ID: | D000069549 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 2016/01/01 | ||||
Date of Entry: | 2015/07/01 | ||||
Revision Date: | 2017/06/20 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Ustekinumab
- Preferred
Stelara
- Narrower
CNTO 1275
- Narrower
Concept UI |
M0490173 |
Scope note | A humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies. |
Preferred term | Ustekinumab |
Concept UI |
M000606473 |
Preferred term | Stelara |
Concept UI |
M0585167 |
Preferred term | CNTO 1275 |
Entry term(s) |
CNTO-1275 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey